Remember why we bought CYDY 4-5 years ago..?? Was it for Covid..NASH..Cancer.. GvH disease..?? Was it for Alzheimer’s..Stroke..Rheumatic diseases..??
Is there a better drug available for HIV.. on the Market..?? In development undergoing Clinical Trials..??
Ask yourselves a simple question..Could Leronlimab be on the market by September 2021..?? If your answer is in the affirmative..What do you think the stock price could be..??
No matter what happens to Covid..AND all the OTHER indications..What if we have just HIV.. under our belt..??
The CYDY management’s attempt to include as many indications as possible..in our portfolio..has been commendable..AND necessary..It is an endeavor to not leave ANY chips on the table..BUT ..If we come up short in Covid AND all other indications..The stock price will take a hit..No doubt..BUT will it change the fact WE ARE THE CLASS ACT IN HIV..?? AND..That Leronlimab is a hop and a skip away from getting approval for HIV..
The exposure that Covid has given CYDY..is worth ANY amount of money we could have paid an advertising agency to bring our name out.. in the Public conscience..!!!
In short..It’s ALL GOOD..Don’t get swayed by the Doomsday Crowd..We’re on track ..and will be GOLDEN by September 2021..
Market Data 
Markets 
AI
